CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLDN4 | Claudin 4 | Cancer-related genes Disease related genes Potential drug targets Predicted membrane proteins Transporters
| | | | | Mixed |
CLDN7 | Claudin 7 | Cancer-related genes Predicted membrane proteins Predicted secreted proteins Transporters
| | | | | Mixed |
CLIC1 | Chloride intracellular channel 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transporters
| | | | | Expressed in all |
CNN1 | Calponin 1, basic, smooth muscle | Cancer-related genes Cytoskeleton related proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
COL17A1 | Collagen, type XVII, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
COL4A2 | Collagen, type IV, alpha 2 | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
COL6A1 | Collagen, type VI, alpha 1 | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
COX17 | COX17 cytochrome c oxidase copper chaperone | Cancer-related genes Mitochondrial proteins Predicted intracellular proteins
| | | | | Expressed in all |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CREBBP | CREB binding protein | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins
| | | | | Expressed in all |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CRYAB | Crystallin, alpha B | Cancer-related genes Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CSE1L | CSE1 chromosome segregation 1-like (yeast) | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CSNK2B | Casein kinase 2, beta polypeptide | Cancer-related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CST3 | Cystatin C | Cancer-related genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Expressed in all |
CST6 | Cystatin E/M | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CSTA | Cystatin A (stefin A) | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Group enriched |
CSTB | Cystatin B (stefin B) | Cancer-related genes Disease related genes Plasma proteins Potential drug targets Predicted intracellular proteins Transporters
| | | | | Tissue enriched |
CTAG1A | Cancer/testis antigen 1A | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CTAG1B | Cancer/testis antigen 1B | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enriched |
CTAG2 | Cancer/testis antigen 2 | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CTNNB1 | Catenin (cadherin-associated protein), beta 1, 88kDa | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
CTSD | Cathepsin D | Cancer-related genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CTSH | Cathepsin H | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
CXCL8 | Chemokine (C-X-C motif) ligand 8 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |
CXCR2 | Chemokine (C-X-C motif) receptor 2 | Cancer-related genes CD markers G-protein coupled receptors Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP19A1 | Cytochrome P450, family 19, subfamily A, polypeptide 1 | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enriched |
CYP1A2 | Cytochrome P450, family 1, subfamily A, polypeptide 2 | Cancer-related genes Enzymes Predicted membrane proteins
| | | | | Tissue enriched |
CYP2C19 | Cytochrome P450, family 2, subfamily C, polypeptide 19 | Cancer-related genes Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2E1 | Cytochrome P450, family 2, subfamily E, polypeptide 1 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enriched |
CYP3A4 | Cytochrome P450, family 3, subfamily A, polypeptide 4 | Cancer-related genes Enzymes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DAXX | Death-domain associated protein | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
DCC | DCC netrin 1 receptor | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted membrane proteins
| | | | | Group enriched |
DCN | Decorin | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
DDB2 | Damage-specific DNA binding protein 2, 48kDa | Cancer-related genes Disease related genes Predicted intracellular proteins
| | | | | Expressed in all |
DEFA1 | Defensin, alpha 1 | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA1B | Defensin, alpha 1B | Cancer-related genes Plasma proteins Predicted secreted proteins Transporters
| | | | | Tissue enriched |
DEFA3 | Defensin, alpha 3, neutrophil-specific | Cancer-related genes Predicted secreted proteins
| | | | | Tissue enriched |
DEK | DEK proto-oncogene | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
DES | Desmin | Cancer-related genes Cytoskeleton related proteins Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Expressed in all |
E2F1 | E2F transcription factor 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Tissue enhanced |
EBAG9 | Estrogen receptor binding site associated, antigen, 9 | Cancer-related genes Predicted intracellular proteins Predicted secreted proteins
| | | | | Expressed in all |
EDN1 | Endothelin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | | | Mixed |
EFNB2 | Ephrin-B2 | Cancer-related genes Plasma proteins Predicted membrane proteins
| | | | | Expressed in all |
EGFR | Epidermal growth factor receptor | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins RAS pathway related proteins
| | | | | Tissue enhanced |
EGR1 | Early growth response 1 | Cancer-related genes Plasma proteins Predicted intracellular proteins Transcription factors
| | | | | Expressed in all |
EIF4E | Eukaryotic translation initiation factor 4E | Cancer-related genes Disease related genes Plasma proteins Predicted intracellular proteins
| | | | | Mixed |
EIF4EBP1 | Eukaryotic translation initiation factor 4E binding protein 1 | Cancer-related genes Predicted intracellular proteins
| | | | | Expressed in all |
ELANE | Elastase, neutrophil expressed | Cancer-related genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enriched |